Baxter International (NYSE:BAX) specializes in the development, manufacture, and marketing of healthcare products, including renal and hospital products. The company operates globally, focusing on critical therapies for life-threatening conditions, as well as products and services related to kidney health, immune disorders, and acute and chronic medical conditions. Through ongoing research and development efforts, Baxter is committed to pioneering in medical innovations that deliver critical therapies for patients in need. The company aims to expand its impact on healthcare by enhancing patient care and driving sustainability in its operations. With a strong presence in both the medical devices and pharmaceutical sectors, Baxter strives to address some of the most challenging healthcare problems facing the world today, always with a focus on improving outcomes for patients and providers.